The resulting HBV-induced ROS accumulation promotes hepatic inflammation through IL-6 upregulation in hepatocellular carcinoma (HCC), concurrently driving constitutive STAT3 activation. This evidence concerns the gene IL6 and hepatocellular carcinoma.